biocryst price target

BioCryst Pharmaceuticals has received a consensus rating of Buy. Similarly, How high will BioCryst go? The 12 analysts offering 12-month...

Given the current short-term trend, the stock is expected to rise 14.81% during the next 3 months and, with a...